Free weekly newsletter
Get the free weekly executive digest
The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Asklepios Bio Pharmaceutical Appoints Mansuo Shannon Chief Scientific Officer
PRIVATEApr 09, 2024•about 2 years ago
Position
Chief Scientific Officer
Company
Asklepios BioPharmaceutical
Research Triangle ParkBiotechnologyHealth CareDescription
Asklepios BioPharmaceutical, the wholly-owned but independently operated subsidiary of Bayer, has appointed Mansuo Shannon new chief scientific officer. The company focuses on using gene therapy technology to develop life-saving medicines in a range of therapy areas.
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months